ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.

Margherita Ambrosini Marzia Del Re Francesco Pantano Andrew E Hendifar Alexander E Drilon Guilherme Harada Anne Hansen Ree Samuel J KlempnerGunhild Mari MælandsmoNorman John Carr Hege G Russnes James M ClearyHarshabad SinghElisa SottotettiAntonia MartinettiGiovanni RandonAndrea Sartore-BianchiIolanda CaponeMassimo MilioneMaria Di BartolomeoFilippo Pietrantonio

Published in: JCO precision oncology (2022)

rearrangements represent an important therapeutic target in individual pretreated patients with GI solid tumors. Further work providing prospective clinical validation of this target is needed.

Keyphrases

advanced non small cell lung cancer
electronic health record
big data
machine learning
young adults
artificial intelligence
deep learning